Bluejay Diagnostics, Inc.
BJDX
$4.00
-$0.03-0.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.59M | -9.40M | -9.74M | -9.95M | -10.04M |
| Total Depreciation and Amortization | 217.90K | 435.10K | 674.90K | 780.90K | 793.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 818.00K | 583.60K | -15.10K | 192.30K | 321.50K |
| Change in Net Operating Assets | -1.31M | 333.60K | 1.41M | 666.70K | 441.70K |
| Cash from Operations | -8.86M | -8.05M | -7.68M | -8.31M | -8.48M |
| Capital Expenditure | -393.50K | -467.80K | -398.90K | -704.20K | -854.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -393.50K | -467.80K | -398.90K | -704.20K | -854.50K |
| Total Debt Issued | 2.00M | 2.00M | -- | -- | -- |
| Total Debt Repaid | -2.29M | -1.92M | -8.40K | -4.80K | -4.40K |
| Issuance of Common Stock | 12.07M | 13.66M | 5.09M | 1.59M | 1.62M |
| Repurchase of Common Stock | -- | 0.00 | -1.50K | -59.10K | -59.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.85M | -2.26M | -1.13M | -415.30K | -433.50K |
| Cash from Financing | 9.93M | 11.48M | 3.95M | 1.11M | 1.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 678.80K | 2.96M | -4.12M | -7.91M | -8.21M |
